Nucletron, an Elekta company, recently launched Esteya, a new approach for treating patients with skin cancer. Esteya electronic brachytherapy mimics proven high dose rate (HDR) brachytherapy by bringing a small X-ray source very close to the cancerous site, enabling the local application of radiation for effective treatment, according to the company. Esteya requires only minimal room shielding, allowing the treatment to occur virtually anywhere patients are seen.

“The highly efficient workflow and easy patient set-up of Esteya make skin cancer treatment extremely easy to plan and deliver,” said John Lapre, Executive Vice President, Elekta Brachytherapy, in a release. “The high dose rate enables delivery of the treatment fraction in less than three minutes. With Esteya, radiation oncologists have access to a safe and patient-friendly treatment that offers a great opportunity to expand radiation therapy services for skin cancer patients.”

For more information, visit www.Esteya.com.